
Biotech firm Sonnet to form $888M HYPE treasury
Nasdaq-listed biotech company Sonnet BioTherapeutics announced a strategic pivot into crypto, unveiling an $888 million entity to launch a Hyperliquid (HYPE) digital asset treasury. On Monday, Sonnet said it formed a business combination with the new